Panton-Valentine leukocidin-producing Staphylococcus aureus necrotising pneumonia: measuring toxin levels in microbiological samples to attest of linezolid clinical efficacy.
Pasquier
P
P
Muller
V
V
Villevieille
T
T
Rousseau
J M
JM
Janvier
F
F
Etienne
J
J
D000081:Acetamides / Q000627:therapeutic use*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001427:Bacterial Toxins / Q000032:analysis / Q000096:biosynthesis*; D016903:Drug Monitoring / Q000379:methods; D005098:Exotoxins / Q000096:biosynthesis*; D006801:Humans; D007956:Leukocidins / Q000096:biosynthesis*; D000069349:Linezolid; D009336:Necrosis / Q000473:pathology*; D023303:Oxazolidinones / Q000627:therapeutic use*; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D013183:Sputum / Q000737:chemistry; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*; D037521:Virulence Factors / Q000096:biosynthesis*
D000081:Acetamides; D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; D023303:Oxazolidinones; C078284:Panton-Valentine leukocidin; D037521:Virulence Factors; D000069349:Linezolid